Dan Mangan is a reporter covering health care and other issues for CNBC.com.
Mangan has been a journalist for more than 20 years, most recently as a general assignment/rewrite reporter at the New York Post. In his more than dozen years at The Post, Mangan routinely covered major stories, including the 9/11 terror attacks, the Bernard Madoff Ponzi scheme, the 2008 financial meltdown and a slew of juicy Gotham scandals du jour, among them the personal tribulations of Yankee slugger Alex Rodriguez.
Prior to that, Mangan began his career in his native Connecticut, writing obituaries for The Hour of Norwalk, before moving on to cover business, government and the court systems at The Hour, the Fairfield County Business Journal and The Advocate of Stamford.
Republican plans to repeal and replace the Affordable Care Act risk being derailed by conservatives opposed to a new bill.
Obamacare currently caps at $500,000 the amount of an executive's compensation that an insurer can deduct as a business expense.
S&P Global Ratings estimates that up to 4 million individual health plan customers and 6 million Medicaid enrollees could lose coverage.
Health insurers would be allowed to deduct their executives' salaries from their taxes, and not just the first $500,000.
Republicans have waited years to get a real chance to repeal the Affordable Care Act.
Republicans have their first real chance to kill Obamacare with the election of President Donald Trump.
EpiPen's seller Mylan came under fire last summer for having increased the price of the auto-injector more than 500 percent.
Republicans previously have promised quick action on gutting and replacing the Affordable Care Act.
Mylan was criticized last year after hiking EpiPen prices to $600, but has seen its stock surge after Donald Trump's election.